Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
第一作者:
L J,Ayash
作者:
医学主题词
腺病毒科(Adenoviridae);抗肿瘤药(Antineoplastic Agents);乳腺肿瘤(Breast Neoplasms);临床方案(Clinical Protocols);综合疗法(Combined Modality Therapy);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);遗传载体(Genetic Vectors);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2);移植预处理(Transplantation Conditioning);bcl-X蛋白质(bcl-X Protein)
PMID
11727734
发布时间
2006-04-21
- 浏览12
Human gene therapy
2023-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



